- Home
- MGM vs EXAS Comparison
MGM vs EXAS Comparison
Compare MGM & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGM
- EXAS
- Stock Information
- Founded
- MGM 1986
- EXAS 1995
- Country
- MGM United States
- EXAS United States
- Employees
- MGM N/A
- EXAS N/A
- Industry
- MGM Hotels/Resorts
- EXAS Medical Specialities
- Sector
- MGM Consumer Discretionary
- EXAS Health Care
- Exchange
- MGM Nasdaq
- EXAS Nasdaq
- Market Cap
- MGM 13.3B
- EXAS 12.3B
- IPO Year
- MGM N/A
- EXAS N/A
- Fundamental
- Price
- MGM $37.27
- EXAS $49.33
- Analyst Decision
- MGM Strong Buy
- EXAS Strong Buy
- Analyst Count
- MGM 13
- EXAS 17
- Target Price
- MGM $53.69
- EXAS $73.07
- AVG Volume (30 Days)
- MGM 4.5M
- EXAS 3.3M
- Earning Date
- MGM 10-30-2024
- EXAS 11-05-2024
- Dividend Yield
- MGM N/A
- EXAS N/A
- EPS Growth
- MGM N/A
- EXAS N/A
- EPS
- MGM 2.82
- EXAS N/A
- Revenue
- MGM $17,221,656,000.00
- EXAS $2,692,328,000.00
- Revenue This Year
- MGM $7.80
- EXAS $12.41
- Revenue Next Year
- MGM $0.35
- EXAS $11.64
- P/E Ratio
- MGM $13.24
- EXAS N/A
- Revenue Growth
- MGM 12.31
- EXAS 11.91
- 52 Week Low
- MGM $33.44
- EXAS $40.62
- 52 Week High
- MGM $48.25
- EXAS $79.62
- Technical
- Relative Strength Index (RSI)
- MGM 44.14
- EXAS 22.62
- Support Level
- MGM $35.74
- EXAS $48.02
- Resistance Level
- MGM $38.59
- EXAS $52.32
- Average True Range (ATR)
- MGM 1.22
- EXAS 2.86
- MACD
- MGM -0.12
- EXAS -1.89
- Stochastic Oscillator
- MGM 24.50
- EXAS 5.28
About MGM MGM Resorts International
MGM Resorts is the largest resort operator on the Las Vegas Strip with 35,000 guest rooms and suites, representing about one fourth of all units in the market. The company's Vegas properties include MGM Grand, Mandalay Bay, Park MGM, Luxor, New York-New York, and Bellagio. The Strip contributed approximately 62% of total EBITDAR in 2023. MGM also owns US regional assets, which represented low-20s of 2023 EBITDAR (MGM's Macao EBITDAR was 17% of the total in 2023). MGM's US sports and iGaming operations are currently a high-single-digit percentage of its total revenue. The company also operates the 56%-owned MGM China casinos with a new property that opened on the Cotai Strip in early 2018. Further, we estimate MGM will open a resort in Japan in 2030.
About EXAS Exact Sciences Corporation
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.